Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

33.3%

1 terminated/withdrawn out of 3 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

33%

1 trials in Phase 3/4

Results Transparency

50%

1 of 2 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

Phase 3

1(100.0%)

1Total

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials

NCT02921035Completed

Non-interventional Study to Assess Adherence to Treatment for Patients With RMS (MAIN-MS)

Role: collaborator

NCT02015286Completed

To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Middle East

Role: collaborator

NCT01497197Phase 3Terminated

A Trial to Compare the Efficacy and Safety of Ovarian Stimulation With GONAL-f® and Luveris® Starting on Day 1 Versus Day 6 in Women Undergoing Assisted Reproductive Technique

Role: collaborator

All 3 trials loaded